Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study.

Published on Jul 30, 2018in Diabetes Care16.019
· DOI :10.2337/DC18-0185
Angela C. Shore58
Estimated H-index: 58
(NIHR: National Institute for Health Research),
Helen M. Colhoun79
Estimated H-index: 79
(Edin.: University of Edinburgh)
+ 19 AuthorsJan Nilsson115
Estimated H-index: 115
(Lund University)
Sources
Abstract
OBJECTIVE Cardiovascular disease (CVD) risk prediction represents an increasing clinical challenge in the treatment of diabetes. We used a panel of vascular imaging, functional assessments, and biomarkers reflecting different disease mechanisms to identify clinically useful markers of risk for cardiovascular (CV) events in subjects with type 2 diabetes (T2D) with or without manifest CVD. RESEARCH DESIGN AND METHODS The study cohort consisted of 936 subjects with T2D recruited at four European centers. Carotid intima-media thickness and plaque area, ankle-brachial pressure index, arterial stiffness, endothelial function, and circulating biomarkers were analyzed at baseline, and CV events were monitored during a 3-year follow-up period. RESULTS The CV event rate in subjects with T2D was higher in those with ( n = 440) than in those without ( n = 496) manifest CVD at baseline (5.53 vs. 2.15/100 life-years, P 2 [16.1–92.2] vs. 19.5 mm 2 [9.5–40.5], P = 0.01). Conventional risk factors, as well as measurements of arterial stiffness and endothelial reactivity, were not associated with CV events. CONCLUSIONS Our observations demonstrate that markers of inflammation and endothelial stress reflect CV risk in subjects with T2D with manifest CVD, whereas the risk for CV events in subjects with T2D without manifest CVD is primarily related to the severity of atherosclerosis.
Figures & Tables
Download
📖 Papers frequently viewed together
34 Citations
85 Citations
References21
Newest
#1Paul M. Ridker (Brigham and Women's Hospital)H-Index: 252
#2Brendan M. Everett (Novartis)H-Index: 41
Last. Robert J. GlynnH-Index: 168
view all 28 authors...
BackgroundExperimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. MethodsWe conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The ...
3,295 CitationsSource
Abstract Life style changes and improved medical therapy have decreased cardiovascular mortality in many countries over the last decades. This has been accompanied by changes in disease characteristics including more non-ST segment elevation myocardial infraction and less vulnerable plaques as assessed by histological analysis of surgical specimens. However, many patients with established disease still suffer from recurrent cardiovascular events in spite of treatment with state-of-the-art-therap...
41 CitationsSource
#1Aidin Rawshani (University of Gothenburg)H-Index: 3
#2Araz Rawshani (University of Gothenburg)H-Index: 18
Last. Soffia Gudbjörnsdottir (University of Gothenburg)H-Index: 50
view all 10 authors...
BackgroundLong-term trends in excess risk of death and cardiovascular outcomes have not been extensively studied in persons with type 1 diabetes or type 2 diabetes. MethodsWe included patients registered in the Swedish National Diabetes Register from 1998 through 2012 and followed them through 2014. Trends in deaths and cardiovascular events were estimated with Cox regression and standardized incidence rates. For each patient, controls who were matched for age, sex, and county were randomly sele...
488 CitationsSource
#1Jamal S. Rana (UCSF: University of California, San Francisco)H-Index: 29
#2Jennifer Y. Liu (KP: Kaiser Permanente)H-Index: 23
Last. Andrew J. Karter (KP: Kaiser Permanente)H-Index: 84
view all 5 authors...
Background For more than a decade, the presence of diabetes has been considered a coronary heart disease (CHD) “risk equivalent”.
64 CitationsSource
#1Peter Libby (Brigham and Women's Hospital)H-Index: 238
#2Gerard Pasterkamp (UU: Utrecht University)H-Index: 94
The concept of the so-called ‘vulnerable plaque’ has proved highly useful to guide research and thinking regarding the pathophysiology of the acute coronary syndromes (ACS). Yet, the time may have come to reconsider this construct, as knowledge has accumulated, the risk profile of the populace has shifted, and our current therapies have reshaped the disease. Over the last several decades, the quest to identify and treat the ‘vulnerable plaque’ has generated much interest.1 Loaded with lipid, mac...
182 CitationsSource
#1Angela C. Shore (University of Exeter)H-Index: 58
#2Helen M. Colhoun (Dund.: University of Dundee)H-Index: 79
Last. Jan Nilsson (Lund University)H-Index: 115
view all 21 authors...
BackgroundThere is a need to develop and validate surrogate markers of cardiovascular disease (CVD) in subjects with diabetes. The macrovascular changes associated with diabetes include aggravated atherosclerosis, increased arterial stiffness and endothelial dysfunction. The aim of this study was to determine which of these factors is most strongly associated with clinically manifest cardiovascular events. MethodsVascular changes were measured in a cohort of 458 subjects with type 2 diabetes (T2...
26 CitationsSource
#1Isabel Gonçalves (Lund University)H-Index: 26
#2Eva Bengtsson (Lund University)H-Index: 24
Last. Jan Nilsson (Lund University)H-Index: 115
view all 26 authors...
Objective— Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins and play important roles in development and tissue repair. They have also been shown to have both protective and pathogenic effects in atherosclerosis, and experimental studies have suggested that MMP-12 contributes to plaque growth and destabilization. The objective of this study was to investigate the associations between circulating MMPs, atherosclerosis burden, and incidence of cardiovascular disease with a par...
55 CitationsSource
#1J van der Leeuw (UU: Utrecht University)H-Index: 2
#2S. van Dieren (UU: Utrecht University)H-Index: 6
Last. Linda M. Peelen (UU: Utrecht University)H-Index: 27
view all 12 authors...
Several cardiovascular prediction models have been developed for application in patients with type 2 diabetes. Their predictive performance in a new set of patients is mostly not established. All available cardiovascular prediction models, identified by a systematic review, were validated in three different cohorts of patients with type 2 diabetes.
39 CitationsSource
#1Anna H. Price (Edin.: University of Edinburgh)H-Index: 4
#2Paul Welsh (Glas.: University of Glasgow)H-Index: 62
Last. Jackie F. Price (Edin.: University of Edinburgh)H-Index: 62
view all 10 authors...
Aims/hypothesis The aim of this study was to investigate the association of N-terminal pro-brain natriuretic peptide (NT-proBNP) with traditional cardiovascular risk factors and incident cardiovascular events in older people with type 2 diabetes.
14 CitationsSource
#1Natalie G. Lumsden (Baker IDI Heart and Diabetes Institute)H-Index: 7
#2Karen L. Andrews (Baker IDI Heart and Diabetes Institute)H-Index: 18
Last. Jaye Chin-Dusting (Baker IDI Heart and Diabetes Institute)H-Index: 40
view all 10 authors...
This single visit study examined whether endothelial function, in addition to cardiovascular (CV) risk factors and plasma microparticle content, was normalised in 15 patients with type 2 diabetes + acute coronary syndrome (ACS) (6 weeks–6 months post cardiac event) undergoing standard clinical care compared to 16 sex- and age-matched healthy controls.Results:While total and low-density lipoprotein (LDL) cholesterol levels were well controlled in the patients with type 2 diabetes + ACS, residual ...
10 CitationsSource
Cited By13
Newest
#1Kunihiko Aizawa (University of Exeter)H-Index: 9
#2Francesco Casanova (University of Exeter)H-Index: 11
Last. Alun D. Hughes (UCL: University College London)H-Index: 82
view all 14 authors...
The parameters derived from reservoir-excess pressure analysis have prognostic utility in several populations. However, evidence in type 2 diabetes (T2DM) remains scarce. We determined if these parameters were associated with T2DM and whether they would predict cardiovascular events in individuals with T2DM. We studied 306 people with T2DM with cardiovascular disease (CVD; DMCVD, 70.4±7.8 years), 348 people with T2DM but without CVD (diabetes mellitus, 67.7±8.4 years), and 178 people without T2D...
Source
#1Angeladine Kenne Malaha (French Institute of Health and Medical Research)
#2Julien Magne (French Institute of Health and Medical Research)H-Index: 22
Last. Victor Aboyans (French Institute of Health and Medical Research)H-Index: 80
view all 10 authors...
Abstract Aims To identify new independent vascular markers to predict cardiovascular events in patients with type-2 diabetes (T2D), and their incremental value compared to the Swedish National Diabetes Register (NDR) risk score. Methods A retrospective cohort study was conducted on 1332 asymptomatic patients with T2D, free from prior CV event, assessed for a cardiovascular work-up, including Duplex ultrasonography to detect plaque on carotid and femoral arteries. The extent of atherosclerosis wa...
Source
Diabetes mellitus (DM) has been linked to an increased prevalence and severity of carotid artery disease, as well as polyvascular disease. Carotid disease is also associated with obesity and abnormal peri- organ and intra-organ fat (APIFat) deposition (i.e., excess fat accumulation in several organs such as the liver, heart and vessels). In turn, DM is associated with APIFat. The coexistence of these comorbidities confers a greater risk of vascular events. Clinicians should also consider that ca...
4 CitationsSource
#1Wen GuoH-Index: 5
#2Xiaona Li (Nanjing Medical University)H-Index: 2
Last. Qun Zhang (Nanjing Medical University)H-Index: 9
view all 9 authors...
Abstract Aims The association between circulating miR-146a and subclinical atherosclerosis in type 2 diabetes mellitus (T2DM) remains poorly understood. This study aimed to investigate the correlation between plasma miR-146a levels and subclinical atherosclerosis as measured by the carotid intima-media thickness (CIMT) and brachial-ankle pulse wave velocity (baPWV) in patients with newly diagnosed T2DM. Methods We studied 100 patients with newly diagnosed T2DM. Subclinical atherosclerosis was de...
Source
#1Michaela Kozakova (UniPi: University of Pisa)H-Index: 29
#2Carmela Morizzo (UniPi: University of Pisa)H-Index: 19
Last. Carlo Palombo (UniPi: University of Pisa)H-Index: 37
view all 6 authors...
PURPOSE It is unclear whether plasma homocysteine (Hcy) has a direct noxious impact on cardiovascular (CV) system or whether its association with cardiovascular events (CVE) is mediated by established risk factors. To explore the role of Hcy in CV impairment, the study evaluated cross-sectional relationships between plasma Hcy and indices of CV organ damage together with the associations of these indices with the history of CVE. METHODS In 269 patients with a high prevalence of diabetes, dyslipi...
6 CitationsSource
#1Małgorzata Waluś-Miarka (Jagiellonian University Medical College)H-Index: 6
#2Aleksandra Trojak (Jagiellonian University Medical College)H-Index: 1
Last. M. T. Malecki (Jagiellonian University Medical College)H-Index: 5
view all 7 authors...
Elevated levels of plasma pentraxin 3 (PTX3), a marker of inflammation, are associated with the risk of developing cardiovascular diseases in the general population, as well as in patients with typ...
1 CitationsSource
#1Corinna Niersmann (HHU: University of Düsseldorf)H-Index: 4
#2K. Röhrig (HHU: University of Düsseldorf)H-Index: 9
Last. Maren Carstensen-Kirberg (HHU: University of Düsseldorf)H-Index: 16
view all 6 authors...
OBJECTIVES: To investigate the impact of omentin on the release of inflammation-related biomarkers and inflammatory pathways in primary human adipocytes. METHODS: Adipocytes were treated with or without omentin (500 and 2,000 ng/mL), and the supernatants were analyzed for inflammation-related biomarkers using proximity extension assay technology. Potential upstream regulators of the omentin-stimulated proteins were identified using Ingenuity Pathway Analysis. Protein levels of components of infl...
1 CitationsSource
Resumen La presencia de diabetes (tipos 1 y 2) incrementa el riesgo de enfermedad cardiovascular aterosclerotica. A pesar de un control metabolico adecuado y un tratamiento de los factores de riesgo vascular hasta alcanzar los objetivos recomendados por las guias clinicas, el riesgo cardiovascular residual de algunos pacientes con diabetes puede ser muy elevado. Es necesario por ello estratificar de la forma mas precisa posible el riesgo vascular del paciente individual. Estrategias consolidadas...
Source
#1Francesco Casanova (University of Exeter)H-Index: 11
#2Andrew R. Wood (University of Exeter)H-Index: 76
Last. Jessica Tyrrell (University of Exeter)H-Index: 34
view all 13 authors...
Urinary albumin-creatinine ratio is a marker of diabetic nephropathy and microvascular damage. Metabolic-related traits are observationally associated with ACR but their causal role is uncertain. Here, we confirmed ACR as a marker of microvascular damage and tested whether metabolic-related traits have causal relationships with ACR. The association between ACR and microvascular function (responses to acetylcholine and sodium nitroprusside) were tested in the SUMMIT study. Two sample Mendelian ra...
3 CitationsSource
#1Paul C. Guest (State University of Campinas)H-Index: 13
: The increase in the human lifespan has not been paralleled by an increase in healthy life. With the increase in the proportion of the aged population, there has been a natural increase in the prevalence of age-related disorders, such as Alzheimer's disease, type 2 diabetes mellitus, frailty, and various other disorders. A continuous rise in these conditions could lead to a widespread medical and social burden. There are now considerable efforts underway to address these deficits in preclinical...
Source